Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

dCas9-KRAB Citations (6)

Originally described in: An enhanced CRISPR repressor for targeted mammalian gene regulation.
Yeo NC, Chavez A, Lance-Byrne A, Chan Y, Menn D, Milanova D, Kuo CC, Guo X, Sharma S, Tung A, Cecchi RJ, Tuttle M, Pradhan S, Lim ET, Davidsohn N, Ebrahimkhani MR, Collins JJ, Lewis NE, Kiani S, Church GM Nat Methods. 2018 Jul 16. pii: 10.1038/s41592-018-0048-5. doi: 10.1038/s41592-018-0048-5.
PubMed Journal

Articles Citing dCas9-KRAB

Articles
Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance. Chung JY, Ain QU, Song Y, Yong SB, Kim YH. Genome Res. 2019 Sep;29(9):1442-1452. doi: 10.1101/gr.246900.118. PubMed
Transcriptional Inhibition of lncRNA gadd7 by CRISPR/dCas9-KRAB Protects Spermatocyte Viability. Zhao J, Ma W, Zhong Y, Deng H, Zhou B, Wu Y, Yang M, Li H. Front Mol Biosci. 2021 Mar 11;8:652392. doi: 10.3389/fmolb.2021.652392. eCollection 2021. PubMed
The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability. Pan Q, Zhong S, Wang H, Wang X, Li N, Li Y, Zhang G, Yuan H, Lian Y, Chen Q, Han Y, Guo J, Liu Q, Qiu T, Jiang J, Li Q, Tan M, Yin H, Peng J, Xiao Y, Qin J. Mol Cell. 2021 Jul 1;81(13):2736-2751.e8. doi: 10.1016/j.molcel.2021.04.009. Epub 2021 Apr 30. PubMed
Substrate Stiffness Drives Epithelial to Mesenchymal Transition and Proliferation through the NEAT1-Wnt/beta-Catenin Pathway in Liver Cancer. Xu X, Zhang Y, Wang X, Li S, Tang L. Int J Mol Sci. 2021 Nov 8;22(21). pii: ijms222112066. doi: 10.3390/ijms222112066. PubMed
An integrated pipeline for mammalian genetic screening. Kramme C, Plesa AM, Wang HH, Wolf B, Smela MP, Guo X, Kohman RE, Chatterjee P, Church GM. Cell Rep Methods. 2021 Sep 27;1(6):100082. doi: 10.1016/j.crmeth.2021.100082. eCollection 2021 Oct 25. PubMed

Associated Plasmids

CKM and TERT dual promoters drive CRISPR-dCas9 to specifically inhibit the malignant behavior of osteosarcoma cells. Hu Y, Zhang H, Guo Z, Zhou J, Zhang W, Gong M, Wu J. Cell Mol Biol Lett. 2023 Jul 6;28(1):52. doi: 10.1186/s11658-023-00464-7. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.